Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 8.30 Delayed Data As of 4:05pm ET |  +0.08 / +0.97%Today’s Change | 7.81 Today|||52-Week Range 19.43 | -46.81% Year-to-Date |
Latest SGMO News | Press Releases
No recent news for Sangamo Therapeutics Inc.
Today’s Trading
| Previous close | 8.22 |
| Today’s open | 8.15 |
| Day’s range | 7.81 - 8.35 |
| Volume | 151,808 |
| Average volume (3 months) | 1,057,722 |
| Market cap | $1.2B |
Data as of 4:05pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | -6.00% |
| Earnings growth (this year) | -47.07% |
| Earnings growth (next 5 years) | +14.14% |
| Revenue growth (last year) | +15.39% |
| P/E ratio | NM |
| Price/Sales | 17.75 |
| Price/Book | 2.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BNGOBionano Genomics Inc | -0.03 | -0.76% |
| OCGNOcugen Inc | -0.08 | -1.24% |
| RGNXRegenxbio Inc | +1.86 | +6.16% |
| AXSMAxsome Therapeutics ... | +0.17 | +0.50% |
Data as of 4:57pm ET, 11/30/2021
Financials
| Next reporting date | March 3, 2022 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $118.2M |
| Annual profit (last year) | -$121.0M |
| Net profit margin | -102.37% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Brisbane, California |
Forecasts
